Chengdu Ucello Biotechnology Co., Ltd.

This early-phase trial tests a new treatment for adults with severe lupus that hasn't responded to standard therapies. The treatment uses specially engineered immune cells from donated umbilical cord blood to target and attack faulty cells driving the disease. The study will enro…